
Symbiotic Meditech Indore Private Limited
About Symbiotic Meditech Indore Private Limited
Data last updated:
Symbiotic Meditech Indore Private Limited is a private limited company based in Indore, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2020PTC051478.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Shashikant Agarwal and Manohar Singh Chouhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 66 Panchu Kumar Ki Chal Near R K Puram Behind Hotels Amaltas Palasia, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.89 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.71 Lakh (net margin 1.5%) and EBITDA of ₹15.78 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 124% over three years.
As per MCA filings, the company has open charges of ₹19.99 Lakh on record.
Symbiotic Meditech Indore Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0034516).
Company details
Recognitions & Rankings of Symbiotic Meditech Indore
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0034516
Contact details
Symbiotic Meditech Indore Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address66 Panchu Kumar Ki Chal Near R K Puram Behind Hotels Amaltas Palasia, Indore, Madhya Pradesh, India – 452001
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Symbiotic Meditech Indore is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Symbiotic Meditech Indore Private Limited, buy the company report.
Financials of Symbiotic Meditech Indore Private Limited
FY 2025 filings availableSymbiotic Meditech Indore Private Limited reported revenue of ₹5.89 Cr (up 575% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 124% over three years, including 575% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symbiotic Meditech Indore Private Limited, buy the company report.
Board of directors of Symbiotic Meditech Indore Private Limited
Symbiotic Meditech Indore has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Shashikant Agarwal Also directs: Jtplus Medico LLP, Tapadiya Interventional Technologies & Healthcare LLP, Healthion Solutions LLP and 5 more | Director | 12 Jun 2020 | 6 Years 4 Months | Current |
| Manohar Singh Chouhan | Director | 12 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Symbiotic Meditech Indore Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tec Pharma Systems India Private Limited | ₹5.94 Cr (FY 2024) | 122.0% | Hyderabad, Telangana, India | |||
| Arya Scientific Instruments Private Limited | ₹5.93 Cr (FY 2025) | -7.0% | Ambala Cantt, Haryana, India | |||
| Inbiosys Systems Private Limited | ₹5.89 Cr (FY 2025) | 10.0% | Delhi, India | |||
| Symbiotic Meditech Indore Private Limitedthis company | ₹5.89 Cr (FY 2025) | ₹8.71 Lakh | 1.5% | 575.0% | Indore, Madhya Pradesh, India | |
| BVM Meditech Private Limited | ₹5.88 Cr (FY 2025) | -34.0% | Delhi, India | |||
| HCS Medicals Private Limited | ₹5.86 Cr (FY 2025) | -40.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Symbiotic Meditech Indore Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Aug 2023 | 100779691 | State Bank of India | ₹19.99 Lakh | Open |
To see the full charge records of Symbiotic Meditech Indore Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Symbiotic Meditech Indore Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Symbiotic Meditech Indore Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Symbiotic Meditech Indore Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Symbiotic Meditech Indore Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Manohar Singh Chouhan was appointed as Director on 12 Jun 2020.
Frequently asked questions
Symbiotic Meditech Indore is an active private limited company based in Indore, Madhya Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 12 June 2020 (6+ years old) and is registered under CIN U51909MP2020PTC051478.
Symbiotic Meditech Indore has 2 current directors:
- Prashant Shashikant Agarwal - Director
- Manohar Singh Chouhan - Director
The latest financial statements of Symbiotic Meditech Indore on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Symbiotic Meditech Indore is U51909MP2020PTC051478. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symbiotic Meditech Indore was incorporated on 12 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Symbiotic Meditech Indore by revenue are Tec Pharma Systems India Private Limited, Arya Scientific Instruments Private Limited, Inbiosys Systems Private Limited, BVM Meditech Private Limited, HCS Medicals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Manohar Singh Chouhan was appointed as Director on 12 Jun 2020. Prashant Shashikant Agarwal was appointed as Director on 12 Jun 2020.
Yes, Symbiotic Meditech Indore is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Symbiotic Meditech Indore is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0034516).
The registered office of Symbiotic Meditech Indore is at 66 Panchu Kumar Ki Chal Near R K Puram Behind Hotels Amaltas Palasia, Indore, Madhya Pradesh, India – 452001.
Symbiotic Meditech Indore operates in the trading industry, in the specialty segment.

